Courtney V. Fletcher

Author

University of Nebraska Medical Center ORCID

Also Known As

C FLETCHER, C Fletcher, C V Fletcher, C. FLETCHER, C. Fletcher, C. V. Fletcher, C. Vail Fletcher, C.V. Fletcher, COURTNEY V. FLETCHER, CV Fletcher

338

Publications

13.3K

Citations

H-Index

180

Concepts

All Affiliations

University of Nebraska Medical Center University of Minnesota Harvard University University of California San Diego University of Colorado Health

About

Courtney V. Fletcher is an author at University of Nebraska Medical Center specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	4	4	100
2	Arts	2	2	85
3	Business	1	1	72
4	Health Sciences	1	1	13
5	Management	1	1	72

Courtney V. Fletcher

169

Publications

10.7K

Citations

H-Index

Page 1

	Year	Citations
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues Courtney V. Fletcher, K A Staskus, Stephen W. Wietgrefe, Proceedings of the National Academy of Sciences	2014	647
Persistent HIV-1 replication maintains the tissue reservoir during therapy Ramón Lorenzo-Redondo, Helen Fryer, Trevor Bedford, Nature Persistent Hiv-1 ReplicationHuman RetrovirusImmunologyAntiviral ResponseVirology	2016	617
Aging and Infectious Diseases: Workshop on HIV Infection and Aging: What Is Known and Future Research Directions Rita B. Effros, Courtney V. Fletcher, Kelly A. Gebo, Clinical Infectious Diseases AgingImmunologyBiogerontologyHuman Immunodeficiency VirusEpidemiology Of Aging	2008	534
Defining total-body AIDS-virus burden with implications for curative strategies Jacob D. Estes, Cissy Kityo, Francis Ssali, Nature Medicine Viral PersistenceTotal-body Aids-virus BurdenVirologyChronic Viral InfectionHiv	2017	400
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis Susan Swindells, Ritesh Ramchandani, Amita Gupta, New England Journal of Medicine	2019	347
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption Meghan Rothenberger, Brandon F. Keele, Stephen W. Wietgrefe, Proceedings of the National Academy of Sciences Viral PersistenceMedicineHuman RetrovirusPathogenesisImmunology	2015	274
Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study Heather J. Ribaudo, David W. Haas, C. Tierney, Clinical Infectious Diseases	2006	220
Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1 Stuart E. Starr, Courtney V. Fletcher, Stephen A. Spector, New England Journal of Medicine	1999	211
Use of Intravitreal Ganciclovir (Dihydroxy Propoxymethyl Guanine) for Cytomegalovirus Retinitis in a Patient With AIDS Keith Henry, Herbert L. Cantrill, Courtney V. Fletcher, American Journal of Ophthalmology Viral PersistenceDihydroxy Propoxymethyl GuanineImmunologyAntiviral Drug DevelopmentAntiviral Therapy	1987	196
Human pharmacokinetics of the antiviral drug DHPG Courtney V. Fletcher, Ronald J. Sawchuk, Barbara J. Chinnock, Clinical Pharmacology & Therapeutics	1986	192

Page 1